CoChat

Diammonium Glycyrrhizinate Attenuates Aβ1–42‐Induced Neuroinflammation and Regulates MAPK and NF‐κB Pathways In Vitro and In Vivo

Open access
Zhao, Hui, Wang, Su‐Lei, Qian, Lai, Jin, Jia‐Li, Li, Hui, Xu, Yun, Zhu, Xiao‐Lei · 2013 · CNS Neuroscience & Therapeutics
Cited by 70

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Summary: Background and purpose: Beta‐amyloid (A β)‐mediated inflammation contributes to the progression and chronicity of A lzheimer's disease (AD), although the exact mechanism remains unclear. This study aimed to investigate whether diammonium glycyrrhizinate (DG) could inhibit A β‐induced inflammation in vitro and in vivo and to explore the underlying mechanisms. Methods: Aβ 1–42 was injected to bilateral hippocampus of mice to make the AD models in vivo. The levels of m RNA and protein of inflammatory cytokines were measured by real‐time PCR and Western blotting, respectively. The viability of SH‐SY 5 Y and HT‐22 cells was determined by MTT. NF‐κ B p65 translocation was analyzed by W estern blotting and immunostaining. Phosphorylation of ERK, p38, and JNK was tested by Western blotting. Results: DG suppressed A β 1–42‐induced activation of microglia and inflammation in vitro and in vivo. The media from A β 1–42‐activated microglia decreased the viability of SH‐SY 5 Y and HT‐22 cells, but it was rescued when pretreated with DG. DG could inhibit the activation of MAPK and NF‐κ B signaling pathways and attenuate the memory deficits in A β 1–42‐induced AD mice. Conclusions: DG protects A β 1–42‐induced AD models in vitro and in vivo through reducing activation of microglia and inflammation, which may be involved in MAPK and NF‐κ B pathways.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cns.12043

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Zhao, H., Wang, S., Qian, L., Jin, J., Li, H., Xu, Y., & Zhu, X.
Venue
CNS Neuroscience & Therapeutics
Publisher
Wiley
Published
2012-12-20
Volume
19
Issue
2
Pages
117-124
ISSN
  • 1755-5930 (ISSN-L)
  • 1755-5949
OpenAlex
W1998784502
Cited by
70
References
3
FWCI
2.82
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.